NASDAQ: INABIn8bio Inc Stock Ownership - Who owns In8bio?
Insider buying vs selling
Have In8bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Peter C. Brandt | Director | 2025-12-22 | 72,464 | $1.38 | $100.00kBuy |
| Emily Fairbairn | Director | 2025-12-22 | 724,637 | $1.38 | $1,000.00kBuy |
| William Taiwei Ho | PRESIDENT AND CEO | 2025-12-22 | 36,232 | $1.38 | $50.00kBuy |
| Patrick McCall | CHIEF FINANCIAL OFFICER | 2025-12-22 | 7,247 | $1.38 | $10.00kBuy |
| Kate Rochlin | Chief Operating Officer | 2025-12-22 | 7,247 | $1.38 | $10.00kBuy |
| Alan S. Roemer | Director | 2025-12-22 | 36,232 | $1.38 | $50.00kBuy |
INAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when INAB insiders and whales buy or sell their stock.
INAB Shareholders
What type of owners hold In8bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Leslie W. Kreis | 97.46% | 9,597,434 | $14.30M | Insider |
| Aaron Gl Fletcher | 97.46% | 9,597,434 | $14.30M | Insider |
| Alyeska Investment Group LP | 9.59% | 944,319 | $1.41M | Institution |
| Franklin Resources Inc | 9.29% | 914,531 | $1.36M | Institution |
| 683 Capital Management LLC | 7.36% | 724,637 | $1.08M | Institution |
| Stonepine Capital Management LLC | 6.74% | 663,412 | $988.48k | Institution |
| Bios Capital Management LP | 1.70% | 167,805 | $250.03k | Institution |
| William Taiwei Ho | 1.27% | 124,817 | $185.98k | Insider |
| Lawrence Lamb | 1.03% | 101,369 | $151.04k | Insider |
| Peter C. Brandt | 1.00% | 98,690 | $147.05k | Insider |
INAB vs Biotech Stocks
In8bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.